Annemie Deiteren
Head of Early Clinical & Experimental Therapeutics Sanofi
Seminars
Thursday 21st May 2026
Strengthening Early Confidence in Dermatology Drug Development: Using Translational Pharmacology Models to Validate Targets Before Patient Trials
11:30 am
- Validating inflammatory pathways through translational human pharmacology models, including inducible skin challenge systems that allow early proof-of-mechanism testing before committing to full patient trials
- Benchmarking multi-pathway modulation against known therapeutic mechanisms to differentiate biological effects and prioritize the most promising targets for further development
- Using early translational pharmacology and experimental therapeutic studies to inform clinical strategy, generating mechanistic evidence that strengthens regulatory discussions and supports progression toward Phase II trials in indications such as HS
